Author

Filippo Severin

Universit

Biography

Filippo Severin is a well-known researcher working in Department of Medicine, University of Padova and has extended valuable service for many years and has been a recipient of many awards and grants.
Title
Cited by
Year
Direct pharmacological targeting of a mitochondrial ion channel selectively kills tumor cells in vivo
L Leanza, M Romio, KA Becker, M Azzolini, L Trentin, A Manago, ...Cancer cell 31 (4), 516-531. e10, 2017201
131
2017
HSP70/HSF1 axis, regulated via a PI3K/AKT pathway, is a druggable target in chronic lymphocytic leukemia
F Frezzato, F Raggi, V Martini, F Severin, V Trimarco, A Visentin, ...International journal of cancer 145 (11), 3089-3100, 2019201
33
2019
Cortactin, a Lyn substrate, is a checkpoint molecule at the intersection of BCR and CXCR4 signalling pathway in chronic lymphocytic leukaemia cells
V Martini, C Gattazzo, F Frezzato, V Trimarco, M Pizzi, G Chiodin, ...British journal of haematology 178 (1), 81-93, 2017201
31
2017
Prognostic and predictive effect of IGHV mutational status and load in chronic lymphocytic leukemia: focus on FCR and BR treatments
A Visentin, M Facco, C Gurrieri, E Pagnin, V Martini, S Imbergamo, ...Clinical Lymphoma Myeloma and Leukemia 19 (10), 678-685. e4, 2019201
29
2019
Major infections, secondary cancers and autoimmune diseases occur in different clinical subsets of chronic lymphocytic leukaemia patients
A Visentin, S Imbergamo, C Gurrieri, F Frezzato, V Trimarco, V Martini, ...European Journal of Cancer 72, 103-111, 2017201
24
2017
Lights and shade of next-generation Pi3k inhibitors in chronic lymphocytic leukemia
A Visentin, F Frezzato, F Severin, S Imbergamo, S Pravato, ...OncoTargets and therapy, 9679-9688, 2020202
18
2020
Profiling B cell chronic lymphocytic leukemia by reverse phase protein array: Focus on apoptotic proteins
F Frezzato, B Accordi, V Trimarco, C Gattazzo, V Martini, G Milani, ...Journal of Leucocyte Biology 100 (5), 1061-1070, 2016201
15
2016
Pharmacological modulation of Kv1. 3 potassium channel selectively triggers pathological B lymphocyte apoptosis in vivo in a genetic CLL model
F Severin, A Urbani, T Varanita, M Bachmann, M Azzolini, V Martini, ...Journal of Experimental & Clinical Cancer Research 41 (1), 64, 2022202
10
2022
Abnormal regulation of BCR signalling by c-Cbl in chronic lymphocytic leukaemia
V Martini, F Frezzato, F Severin, F Raggi, V Trimarco, L Martinello, ...Oncotarget 9 (63), 32219, 20120
8
2018
Targeting of HSP70/HSF1 axis abrogates in vitro ibrutinib-resistance in chronic lymphocytic leukemia
F Frezzato, A Visentin, F Severin, S Pizzo, E Ruggeri, N Mouawad, ...Cancers 13 (21), 553, 2021202
4
2021
Protective role immunoglobulin replacement therapy in chronic lymphocytic leukemia: FOCUS on subcutaneous immunoglobulin formulations
A Visentin, FR Mauro, S Rosati, S Imbergamo, E Scomazzon, S Pravato, ...Blood 13, 4954, 01801
2
2018
Inhibition of JAK2/STAT3 pathway leads to apoptosis in chronic lymphocytic leukemia cells
Inhibition of JAK/STAT3 pathway leads to apoptosis in chronic lymphocytic leukemia cellsF Severin, F Frezzato, V Martini, F Raggi, V Trimarco, L Martinello, ...Blood, The Journal of the American Society of Hematology 18 (), 03-03, 01601
2
2016
HSP70-HSF1 Interplays Has a Role in the Pathogenesis of Chronic Lymphocytic Leukemia and Is a Druggable Target
F Frezzato, F Raggi, F Severin, V Martini, V Trimarco, L Martinello, M Pizzi, ...Blood 18 (), 4368, 01601
2
2016
Evaluation of Integrated CLL Scoring System (ICSS) in 420 Patients with Chronic Lymphocytic Leukemia
A Visentin, F Frezzato, S Imbergamo, V Trimarco, V Martini, F Severin, ...Blood, The Journal of the American Society of Hematology 28 (22), 5563-5563, 20620
1
2016
Cortactin is a new player in aggressiveness and diffusion of chronic lymphocytic leukaemia
V Martini, F Frezzato, V Trimarco, M Pizzi, G Chiodin, F Severin, ...Blood 28 (22), 4353, 20620
1
2016